A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 39/395 (2006.01) A61K 31/70 (2006.01) A61K 31/7088 (2006.01) A61K 38/44 (2006.01) A61K 39/02 (2006.01) A61P 31/04 (2006.01) C12N 9/02 (2006.01) A61K 38/00 (2006.01) A61K 39/00 (2006.01)
Patent
CA 2341639
Compositions comprising Cu,Zn-Superoxide dismutase (Cu,Zn-SOD), nucleic acid encoding a Cu,Zn-SOD and/or antibody to a Cu,Zn-SOD are described as well as their use as vaccines. Also described are methods for isolation of Cu,Zn-SODs and for preparation of pharmaceutical compositions, preferably for providing or eliciting protective immunity to meningococcal infection in an animal.
L'invention concerne des compositions comprenant une Cu,Zn-superoxyde dismutase (Cu,Zn-SOD), un acide nucléique codant Cu,Zn-SOD et/ou un anticorps dirigé contre Cu,Zn-SOD, de même que l'utilisation de ces compositions en tant que vaccins. L'invention concerne encore des procédés d'isolation de Cu-Zn-superoxyde dismutases et de préparation de compositions pharmaceutiques destinées, de préférence, à apporter ou supprimer une immunité protégeant contre une infection méningococcique, chez un animal.
Gorringe Andrew Richard
Kroll John Simon
Langford Paul Richard
Robinson Andrew
Goudreau Gage Dubuc
Health Protection Agency
Imperial College Of Science Technology And Medicine
Microbiological Research Authority
LandOfFree
Superoxide dismutase as a vaccine antigen does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Superoxide dismutase as a vaccine antigen, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Superoxide dismutase as a vaccine antigen will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1537314